Adapting to change often requires letting go of the old to make room for the new. This could mean abandoning habits, routines ...

DWTX READ THE FULL DWTX RESEARCH REPORT Business Update First Patient Dosed in Phase 2b Trial of Halneuron® On March 18, 2025 ...

Japan's health gains over the past 30 years are now stalling, with rising regional disparities. The increasing burdens of ...

Likewise, we expect to initiate our first-in-human Phase 1 trial with ... mouse model studies, with the first planned to begin in H1-2025. The studies will evaluate the effects of IC 100 on body ...

Recursion Pharmaceuticals—a relatively small company backed by the chip giant Nvidia—is betting that its massive ...

Tina Romani; Investor Relations; Petco Health and Wellness Company Inc. Joel Anderson; Chief Executive Officer; Petco Health and Wellness Company Inc. Sabrina Simmon ...

The Los Angeles County Board of Supervisors has voted to establish a new consolidated department dedicated to homeless ...

Operator: Greetings and welcome to the Aqua Metals Q4 and Full Year Investor Conference Call. At this time, all participants ...

Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptides and proteins replacement therapies, today reported financial results and key ...

This is the midway point for a three-year, phase-in approach of proposed ... It adopted Year 1 of the adjustments on March 26, 2024. The changes took effect July 1. Asheville water has been ...

Huang and colleagues examined neural responses in mouse anterior cingulate cortex (ACC) during a discrimination-avoidance task. The authors present useful findings that ACC neurons encode primarily ...